Companion Diagnostics Partnering Terms & Agreements

1
Companion Diagnostics Partnering Terms
Agreements  
One-Stop Shop for Business Information
2
Summary
The Companion Diagnostics Partnering Terms and
Agreements report provides comprehensive
understanding and unprecedented access to the
companion diagnostics partnering deals and
agreements entered into by the worlds leading
healthcare companies. The report provides a
detailed understanding and analysis of how and
why companies enter companion diagnostic
partnering deals. The majority of deals are
discovery or development stage whereby the
licensee obtains a right or an option right to
license the licensors companion diagnostics
technology. These deals tend to be multi
component, starting with collaborative RD, and
commercialization of outcomes.
3
Understanding the flexibility of a prospective
partners negotiated deals terms provides
critical insight into the negotiation process in
terms of what you can expect to achieve during
the negotiation of terms. Whilst many smaller
companies will be seeking details of the payments
clauses, the devil is in the detail in terms of
how payments are triggered contract documents
provide this insight where press releases do
not. This report contains over 250 links to
online copies of actual companion diagnostics
deals and contract documents as submitted to the
Securities Exchange Commission by companies and
their partners. Contract documents provide the
answers to numerous questions about a prospective
partners flexibility on a wide range of
important issues, many of which will have a
significant impact on each partys ability to
derive value from the deal.
4
The initial chapters of this report provide an
orientation of companion diagnostics deal making
and business activities. Chapter 1 provides an
introduction to the report, whilst chapter 2
provides an overview of the trends in companion
diagnostics deal making since 2007, including
details of average headline, upfront, milestone
and royalty terms.Chapter 3 provides a review
of the leading companion diagnostics deals since
2007. Deals are listed by headline value, signed
by big pharma, and most active of all bio pharma
companies. Where the deal has an agreement
contract published at the SEC a link provides
online access to the contract.
5
Chapter 4 provides a comprehensive listing of the
top 50 big pharma companies with a brief summary
followed by a comprehensive listing of sensory
organ deals, as well as contract documents
available in the public domain. Where available,
each deal title links via Weblink to an online
version of the actual contract document,
providing easy access to each contract document
on demand. Chapter 5 provides comprehensive
access to all sensory organ deals since 2007
where a deal contract is available, providing the
user with direct access to contracts as filed
with the SEC regulatory authorities. Each deal
title links via Weblink to an online version of
the deal record contract document, providing easy
access to each contract document on demand.
6
Chapter 6 provides a comprehensive and detailed
review of companion diagnostics partnering deals
signed and announced since January 2007. The
chapter is organized by specific biomarker
technology type in focus. Each deal title links
via Weblink to an online version of the deal
record and where available, the contract
document, providing easy access to each contract
document on demand. The report also includes
numerous tables and figures that illustrate the
trends and activities in companion diagnostics
partnering and dealmaking since 2007. In
conclusion, this report provides everything a
prospective dealmaker needs to know about
partnering in the research, development and
commercialization of companion diagnostics
technologies and products.
7
Table of Contents

1. Introduction
2. Trends in companion diagnostics deal making
3. Leading companion diagnostics deals
4. Big pharma companion diagnostics deals
5. Companion diagnostics deal making directory
6. Companion diagnostics deal making by technology
   type
7. Companion diagnosticss partnering resource center

8
Related Reports

• Distribution Partnering Terms and Agreements in
  Pharma, Biotech and Diagnostics
• 2014 Analysis of the French Hospital Cancer
  Diagnostics Market
• 2014 Analysis of the French Molecular Diagnostics
  Market Outlook Innovations, Trends and
  Opportunities for Suppliers
• 2014 Analysis of the UK Hospital Cancer
  Diagnostics Market
• 2014 Molecular Diagnostics Market Strategic
  Assessments of Major Suppliers

9
Custom Research

• Incase the reports dont match your
  requirement then we can do a Custom Research for
  you. Our multifarious capabilities, cross-sector
  expertise and detailed knowledge of various
  markets, put us at a unique position to take up
  Custom Research demands of yours. We provide the
  specifications of the custom research job to a
  dedicated team comprising of researchers,
  analysts and industry experts, who have close
  experience and understanding of global markets,
  competitive landscapes, various business models,
  market shares, drivers, restraints and
  benchmarks.
• http//www.bharatbook.com/customResearch.asp

10
For More Information You Can Visit

• http//www.bharatbook.com/Healthcare-market-resear
  ch-reports/Companion-Diagnostics-Partnering-Terms-
  Agreements.html

Request Sample Pages
Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 For Live
Chat - http//bit.ly/19m3TU4
Follow/Like Us on-